In a new study, Australian researchers recruited adolescents with autism spectrum disorders and administered a single dose each of oxytocin and placebo via a nasal spray, received one week apart. Compared to administration of the placebo spray, the subjects' performance on a facial expression task that measures emotion recognition was improved when they received the oxytocin spray.